Related Experiment Video
Updated: Oct 12, 2025

09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
30.4K
Data on known anti-virals in combating CoVid-19
L Akshayaa1, Thangavelu Lakshmi1, Ezhilarasan Devaraj1
1Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai-600077, TamilNadu.
Bioinformation
|November 22, 2021
Summary
Ivermectin and remdesivir show potential for managing COVID-19. Both drugs are effective against SARS-CoV-2 replication, offering new therapeutic avenues for this global health challenge.
Area of Science:
- Virology
- Infectious Diseases
- Drug Discovery
Background:
- Developing effective antivirals for COVID-19 (Coronavirus Disease 2019) presents a significant global challenge.
- Existing treatments include chloroquine, lopinavir, favipiravir, and remdesivir.
- Ivermectin and remdesivir are known to be effective against filoviruses and paramyxoviruses.
Purpose of the Study:
- To investigate the potential therapeutic applications of ivermectin and remdesivir in managing COVID-19.
- To evaluate the efficacy of these drugs against SARS-CoV-2 replication.
Main Methods:
- Review of existing scientific literature on ivermectin and remdesivir.
- Analysis of data regarding the antiviral activity of these compounds against SARS-CoV-2.
- Comparative assessment of efficacy against related viral families.
Main Results:
- Both ivermectin and remdesivir demonstrate efficacy against filoviruses and paramyxoviruses.
- Available data indicates that ivermectin and remdesivir can inhibit the replication of SARS-CoV-2.
- These findings suggest a potential role for these drugs in COVID-19 treatment.
Conclusions:
- Ivermectin and remdesivir show promise as potential agents for the management of COVID-19.
- Further clinical investigation is warranted to confirm the therapeutic benefits of ivermectin and remdesivir for COVID-19 patients.
More Related Videos
Related Concept Videos
Subviral Agents
188
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
188
Antimicrobial Effectiveness
386
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
386
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
15
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
15
Retrovirus Life Cycles
47.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.6K

